Table 4 Tests for melanoma in the last yeara
From: Use of shared care and routine tests in follow-up after treatment for localised cutaneous melanoma
|  | Stage 0 (n = 36) | Stage IA (n = 39) | Stage IB (n = 52) | Stage IIA (n = 55) | Stage IIB/C (n = 48)b | Total (n = 230)b,c |
|---|---|---|---|---|---|---|
Underwent any tests in the past year for surveillance of melanoma | 6 (17) | 5 (13) | 29 (56) | 29 (53) | 32 (70) | 101 (37) |
Type of test performedd | ||||||
 Chest X-ray | 0 (0) | 1 (3) | 10 (19) | 11 (20) | 9 (20) | 31 (11) |
 Blood test | 2 (6) | 3 (8) | 8 (15) | 13 (24) | 13 (28) | 39 (13) |
 CT scan | 0 (0) | 0 (0) | 6 (12) | 10 (18) | 14 (30) | 30 (8) |
 Biopsy | 2 (6) | 2 (5) | 4 (8) | 3 (6) | 0 (0) | 11 (6) |
 MRI | 1 (3) | 0 (0) | 1 (2) | 1 (2) | 1 (2) | 4 (2) |
 PET scan | 1 (3) | 0 (0) | 3 (6) | 4 (7) | 7 (15) | 15 (5) |
 Ultrasonography | 0 (0) | 1 (3) | 9 (17) | 9 (16) | 9 (20) | 28 (10) |
 Othere | 0 (0) | 0 (0) | 1 (2) | 1 (2) | 0 (0) | 3 (2) |